.jpg)
India's pharmaceutical industry is entering a transformative phase, driven by continuous innovation, expanding global healthcare demands, regulatory excellence, and the country's growing prominence as a trusted pharmaceutical manufacturing and life sciences hub.
Among the sectors spearheading this transformation are Pharma Finished Dosage Contract Manufacturing Companies, which have become indispensable partners for pharmaceutical innovators, branded drug manufacturers, and global healthcare organizations.
Equally significant is the rapid advancement of... >>More
Dr Rajiv Chhibber, Joint Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
Suneela Thatte, VP & Head – Healthcare R&D (India), Merck KGaA
Rami Mehio, VP & Head - Software and Informatics Development, Illumina
Nilesh Pendse, Director - Vaccines, Pfizer India
Rehan Khan, Managing Director, MSD India
Jennifer Li, SVP & Head of Sales - APAC, Medidata
Dr Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis